GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
737
c/compounding·posted 2 years ago by u/chidi_demir

[Lab] SSA survo — Medutest came back 97.4% against a claimed 96.2%

Explainer The Quiet One ×1

Been lurking in c/trialwatch for about 10 months and finally have something worth posting.

Short version: week 46, 0.5mg, and compounding is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 11 threads, and the answers split roughly down the middle.

What I actually want to know is whether the people saying it does not matter have measured it, or whether it is just repeated confidently. Happy to be told I am overthinking this — I probably am — but I would rather overthink it now than at week 40.

759 up / 22 down97% upvoted26 commentsid jqfmhf24 Oct 2023

26 comments

15 in this archive, depth 5

best — the order this archive was captured in

u/sofia_nascimento128 points·2 years ago

Which state? Rules vary.

replysharereportpermalink
u/amara_kuipers97 points·2 years ago

The telehealth + compounding combo cost API source plus 11% markup. Not cheap but covered by insurance depending on state.

replysharereportpermalink
u/zaid_grimaldi113 points·2 years ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink
u/eu_apotheke_a77 points·2 years ago

What is the actual shortage list status right now?

replysharereportpermalink
u/chidi_demirOP49 points·2 years ago·edited

The telehealth + compounding combo cost 503A plus 3% markup. Not cheap but covered by insurance depending on state.

replysharereportpermalink
u/marit_laurent88 points·2 years ago

Yeah, 503A and 503B are different regulatory animals.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/mateusz_adebayo73 points·2 years ago

shortage list status is telehealth, check the actual list

replysharereportpermalink
u/chidi_demirOP-9 points·2 years ago

Asked 23 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.

replysharereportpermalink
u/niels_roos1 point·2 years ago

the Poland situation is different from the US, different regulations

replysharereportpermalink
u/kavya_kravchenko73 points·2 years ago

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

replysharereportpermalink
u/controversial_only59 points·2 years ago·edited

state board rules differ, say which state

replysharereportpermalink
u/fatima_kowalski0 points·2 years ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink
u/anya_antonsen1 point·2 years ago·edited

the 503A/503B distinction is load-bearing, do not blur it

replysharereportpermalink
u/hugo_bergstrom1 point·2 years ago

API transparency is the question that separates good compounders from sketchy ones

replysharereportpermalink
u/ferran_mensah20 points·2 years ago

no pharmacy referral codes, naming is fine, recruiting is not

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →